Suppr超能文献

2.4G2是一种针对巨噬细胞Fcγ受体的单克隆抗体,可与小鼠T细胞Fcγ受体及IgG结合因子发生反应。

2.4G2, a monoclonal antibody to macrophage Fc gamma receptors, reacts with murine T cell Fc gamma receptors and IgG-binding factors.

作者信息

Daëron M, Néauport-Sautès C, Blank U, Fridman W H

出版信息

Eur J Immunol. 1986 Dec;16(12):1545-50. doi: 10.1002/eji.1830161213.

Abstract

In order to determine whether T cell Fc gamma receptors (Fc gamma R) and IgG-binding factors (IgG-BF) are structurally related, we searched for common antigens on these molecules. We found that the anti-macrophage Fc gamma 1/gamma 2bR monoclonal antibody 2.4G2 binds to similar determinant(s) on the macrophage-like J774 cells and on the Fc gamma R+ hybridoma T cells T2D4. On the T cell membrane, these determinants are associated with Fc gamma 1/gamma 2bR. They are absent on Fc gamma R- hybridoma T cells or the FcR- BW5147 thymoma cells. 2.4G2-reactive molecules were also detected in soluble material either extracted or released in the supernatant of Fc gamma R+ hybridoma T cells. 2.4G2-reactive molecules released in the supernatant of T2D4 cells could be absorbed on Sepharose beads coupled to rabbit IgG and they were recovered by acid elution. Conversely, Sepharose beads coupled to 2.4G2 retained molecules which had affinity for rabbit IgG, which suppressed an in vitro antibody response and which had the same molecular weight as IgG-BF. These results indicate that T cell Fc gamma R and IgG-BF share common epitopes and that 2.4G2 can serve as an anti-IgG-BF antibody.

摘要

为了确定T细胞Fcγ受体(FcγR)和IgG结合因子(IgG-BF)在结构上是否相关,我们在这些分子上寻找共同抗原。我们发现抗巨噬细胞Fcγ1/γ2bR单克隆抗体2.4G2与巨噬细胞样J774细胞以及FcγR⁺杂交瘤T细胞T2D4上的相似决定簇结合。在T细胞膜上,这些决定簇与Fcγ1/γ2bR相关。它们在FcγR⁻杂交瘤T细胞或FcR⁻BW5147胸腺瘤细胞上不存在。在从FcγR⁺杂交瘤T细胞上清液中提取或释放的可溶性物质中也检测到了2.4G2反应性分子。T2D4细胞上清液中释放的2.4G2反应性分子可被偶联兔IgG的琼脂糖珠吸附,并通过酸洗脱回收。相反,偶联2.4G2的琼脂糖珠保留了对兔IgG有亲和力、抑制体外抗体反应且分子量与IgG-BF相同的分子。这些结果表明T细胞FcγR和IgG-BF共享共同表位,并且2.4G2可作为抗IgG-BF抗体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验